These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35123418)

  • 1. Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil.
    Prete CA; Buss LF; Buccheri R; Abrahim CMM; Salomon T; Crispim MAE; Oikawa MK; Grebe E; da Costa AG; Fraiji NA; do P S S Carvalho M; Whittaker C; Alexander N; Faria NR; Dye C; Nascimento VH; Busch MP; Sabino EC
    BMC Infect Dis; 2022 Feb; 22(1):127. PubMed ID: 35123418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling of Waning of Immunity and Reinfection Induced Antibody Boosting of SARS-CoV-2 in Manaus, Brazil.
    Wei H; Musa SS; Zhao Y; He D
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil.
    Naveca FG; Nascimento VA; Nascimento F; Ogrzewalska M; Pauvolid-Corrêa A; Araújo MF; Arantes I; Batista ÉR; Magalhães AÁ; Vinhal F; Mattos TP; Riediger I; Debur MDC; Grinsztejn B; Veloso VG; Brasil P; Rodrigues RR; Rovaris DB; Fernandes SB; Fernandes C; Santos JHA; Abdalla LF; Costa-Filho R; Silva M; Souza V; Costa ÁA; Mejía M; Brandão MJ; Gonçalves LF; Silva GA; de Jesus MS; Pessoa K; Corado ALG; Duarte DCG; Machado AB; Zukeram KA; Valente N; Lopes RS; Pereira EC; Appolinario LR; Rocha AS; Tort LFL; Sekizuka T; Itokawa K; Hashino M; Kuroda M; Dezordi FZ; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Bello G; Resende PC
    Sci Rep; 2023 May; 13(1):7306. PubMed ID: 37147348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study.
    Prete CA; Buss LF; Whittaker C; Salomon T; Oikawa MK; Pereira RHM; Moura ICG; Delerino L; Barral-Netto M; Tavares NM; Franca RFO; Boaventura VS; Miyajima F; Mendrone-Junior A; de Almeida-Neto C; Salles NA; Ferreira SC; Fladzinski KA; de Souza LM; Schier LK; Inoue PM; Xabregas LA; Crispim MAE; Fraiji N; Araujo FLV; Carlos LMB; Pessoa V; Ribeiro MA; de Souza RE; da Silva SMN; Cavalcante AF; Valença MIB; da Silva MV; Lopes E; Filho LA; Mateos SOG; Nunes GT; Silva-Junior AL; Busch MP; Castro MC; Dye C; Ratmann O; Faria NR; Nascimento VH; Sabino EC
    Elife; 2022 Sep; 11():. PubMed ID: 36135358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
    Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
    Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
    Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
    Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
    Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
    Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of COVID-19 in Amazonia: A history of government denialism and the risk of a third wave.
    Ferrante L; Duczmal LH; Capanema E; Steinmetz WAC; Almeida ACL; Leão J; Vassão RC; Fearnside PM; Tupinambás U
    Prev Med Rep; 2022 Apr; 26():101752. PubMed ID: 35242505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection.
    Hoeggerl AD; Nunhofer V; Weidner L; Lauth W; Zimmermann G; Badstuber N; Grabmer C; Kartal O; Jungbauer C; Neureiter H; Held N; Ortner T; Flamm M; Osterbrink J; Rohde E; Laner-Plamberger S
    Infect Dis (Lond); 2024 Nov; 56(11):954-964. PubMed ID: 38869944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 12. Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant.
    Coutinho RM; Marquitti FMD; Ferreira LS; Borges ME; da Silva RLP; Canton O; Portella TP; Poloni S; Franco C; Plucinski MM; Lessa FC; da Silva AAM; Kraenkel RA; de Sousa Mascena Veras MA; Prado PI
    Commun Med (Lond); 2021; 1():48. PubMed ID: 35602219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
    Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
    Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
    Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
    BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
    Carazo S; Skowronski DM; Brisson M; Barkati S; Sauvageau C; Brousseau N; Gilca R; Fafard J; Talbot D; Ouakki M; Gilca V; Carignan A; Deceuninck G; De Wals P; De Serres G
    Lancet Infect Dis; 2023 Jan; 23(1):45-55. PubMed ID: 36152671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil.
    Romano CM; Felix AC; Paula AV; Jesus JG; Andrade PS; Cândido D; Oliveira FM; Ribeiro AC; Silva FCD; Inemami M; Costa AA; Leal COD; Figueiredo WM; Pannuti CS; Souza WM; Faria NR; Sabino EC
    Rev Inst Med Trop Sao Paulo; 2021; 63():e36. PubMed ID: 33909850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; Coyle P; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Tang P; Al Kanaani Z; Al Kuwari E; Butt AA; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Al Khal A; Bertollini R
    PLoS Med; 2021 Dec; 18(12):e1003879. PubMed ID: 34914711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the unexpected dynamics of COVID-19 in Manaus, Brazil.
    He D; Artzy-Randrup Y; Musa SS; Gräf T; Naveca F; Stone L
    Infect Dis Model; 2024 Jun; 9(2):557-568. PubMed ID: 38545442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Al-Otaiby M; Krissaane I; Al Seraihi A; Alshenaifi J; Qahtani MH; Aljeri T; Zaatari E; Hassanain M; Algwizani A; Albarrag A; Al-Mozaini M; Alabdulaali M
    Int J Infect Dis; 2022 Sep; 122():758-766. PubMed ID: 35840098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.